3//SEC Filing
Bioengine Capital Inc. 3
Accession 0001213900-19-004601
CIK 0000946486other
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 12:17 PM ET
Size
8.5 KB
Accession
0001213900-19-004601
Insider Transaction Report
Form 3
Bioengine Capital Inc.
10% Owner
Holdings
SERIES F WARRANTS
Exercise: $3.68From: 2018-12-24Exp: 2020-06-24→ COMMON STOCK (384,824 underlying)- 3,551,750
COMMON STOCK
SERIES G WARRANTS
Exercise: $4.05From: 2018-12-24Exp: 2023-12-24→ COMMON STOCK (747,012 underlying)
Center Laboratories, Inc.
10% Owner
Holdings
- 3,551,750
COMMON STOCK
SERIES G WARRANTS
Exercise: $4.05From: 2018-12-24Exp: 2023-12-24→ COMMON STOCK (747,012 underlying)SERIES F WARRANTS
Exercise: $3.68From: 2018-12-24Exp: 2020-06-24→ COMMON STOCK (384,824 underlying)
Footnotes (3)
- [F1]The shares are directly held by Bioengine Capital Inc. and indirectly held by Center Laboratories, Inc., which owns 58.6% of Bioengine Capital Inc.
- [F2]The exercisable shares of Series F Warrants will be directly held by Bioengine Capital Inc. and indirectly held by Center Laboratories, Inc.
- [F3]The exercisable shares of Series G Warrants will be directly held by Bioengine Capital Inc. and indirectly held by Center Laboratories, Inc.
Documents
Issuer
WINDTREE THERAPEUTICS INC /DE/
CIK 0000946486
Entity typeother
IncorporatedTaiwan, Province of China
Related Parties
1- filerCIK 0001770197
Filing Metadata
- Form type
- 3
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 12:17 PM ET
- Size
- 8.5 KB